ScottDLeeMD
Gastroenterology • Seattle, WAAssociate Professor, Medicine, University of Washington School of Medicine
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4377Fax+1 206-598-4732
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994
Certifications & Licensure
WA State Medical License 1997 - 2025
IL State Medical License 2000 - 2002- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Asacol Dosing Study for Active Ulcerative Colitis Start of enrollment: 2003 Jun 01
- Induction of Clinical Response Using Rifaximin in Crohn's Disease Start of enrollment: 2008 Nov 01
- Study of Cimzia for the Treatment of Ulcerative Colitis Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- 428 citationsUstekinumab as Induction and Maintenance Therapy for Crohn's Disease.Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang
The New England Journal of Medicine. 2016-11-17 - 365 citationsVedolizumab as induction and maintenance therapy for Crohn's disease.William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel
The New England Journal of Medicine. 2013-08-22 - 5 citationsTofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.Scott David Lee, Anand Singla, Jason Harper, Mitra Barahimi, Jeffrey Jacobs
Digestive Diseases and Sciences. 2022-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
